Does USTEKINUMAB Cause Liver disorder? 1,089 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,089 reports of Liver disorder have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.3% of all adverse event reports for USTEKINUMAB.
1,089
Reports of Liver disorder with USTEKINUMAB
1.3%
of all USTEKINUMAB reports
696
Deaths
771
Hospitalizations
How Dangerous Is Liver disorder From USTEKINUMAB?
Of the 1,089 reports, 696 (63.9%) resulted in death, 771 (70.8%) required hospitalization, and 765 (70.2%) were considered life-threatening.
Is Liver disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,089 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Liver disorder?
METHOTREXATE (3,119)
ADALIMUMAB (2,502)
ETANERCEPT (1,990)
TOCILIZUMAB (1,853)
ABATACEPT (1,759)
RITUXIMAB (1,736)
ACETAMINOPHEN (1,723)
LEFLUNOMIDE (1,599)
TOFACITINIB (1,584)
HYDROXYCHLOROQUINE (1,514)
Which USTEKINUMAB Alternatives Have Lower Liver disorder Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE